User account menu Search Menu Novartis Financial Data Novartis SEC Filings In accordance with US securities regulations, Novartis files reports with the Securities and Exchange Commission. View all of the Novartis filings through EDGAR, the Electronic Data Gathering, Analysis and Retrieval system, on the SEC website. SEC filings (EDGAR) Related Links Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London Novartis announces FDA and EMA filing acceptances of Beovu® for patients with diabetic macular edema Novartis achieves important regulatory milestone for AMG 334 (erenumab) in migraine prevention with EMA filing acceptance FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101) Novartis Navigate Topics Explore Companies Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all